PROVIDER FILE · The cost notebook

Slim Now TN Review: Monthly GLP-1 Prices and the First-Payment Question

The Tennessee practice publishes semaglutide and tirzepatide prices with consultation or follow-up services, but its general $195 first-month offer does not clearly align with every medication listing.

A useful GLP-1 price is one you can connect to an actual first bill. Slim Now TN provides more detail than a single starting-price advertisement: its website lists monthly semaglutide and tirzepatide options, identifies included clinical services, and describes medication for home administration. Yet the most immediate budgeting question remains unresolved. A general offer advertises the first month at $195, while the initial semaglutide listing says $85 per month with an initial consultation included. The consulted material does not explain which amount would apply to that enrollment.

This documentary review examines what those prices establish, what could change later, and which responsibilities remain unclear before payment. Slim Now TN advertises a Murfreesboro office and telehealth visits within Tennessee, making local access part of the cost calculation rather than a minor detail. Sources were consulted October 19, 2026; that is a research date, not confirmation that every page was updated then. The central finding is a reasonably detailed advertised price schedule paired with incomplete documentation of billing terms, pharmacy arrangements, and the exact products supplied.

At a glance

First-month discrepancy
The general first-month offer is $195, but the initial semaglutide listing is $85 per month and includes an initial consultation. The sources do not reconcile them.
Sources: [3]
Semaglutide schedule
Advertised monthly prices are $85 for the 0.25 mg listing, $125 for 0.50 mg, $200 for 1 mg, $250 for 1.50 mg, and $300 for 2 mg.
Sources: [3]
Tirzepatide schedule
Advertised monthly prices are $195 for the 2.5 mg listing, $295 for 5 mg, $395 for 7.5 mg, and $495 for 10 mg.
Sources: [3]
Tennessee access
Slim Now TN lists an office at 5607 Franklin Rd, Murfreesboro, TN 37128, and advertises telehealth visits in Tennessee.
Sources: [3]
Product and billing limits
The consulted materials do not identify the dispensing pharmacy or exact formulations, or establish cancellation, refund, automatic-renewal, or insurance terms.
Sources: [3]

Start with the amount due, not the headline

Slim Now TN’s general pricing introduction says, “For the first month we offer this program for $195,” followed by a schedule for later payments. That sounds straightforward until the medication-specific listings enter the picture. Tirzepatide’s 2.5 mg option also says $195 per month, but semaglutide’s 0.25 mg option says $85 per month. Both initial listings describe an included consultation. The evidence does not establish whether the general offer applies only to one medicine or reflects a different arrangement.

That discrepancy should not be resolved by assuming either the cheapest or the most prominent figure wins. Ask the office to identify the medication-specific first charge, the services it covers, and whether any other payment is due before medication is supplied. Our explanation of why the first GLP-1 payment can differ from the monthly price provides a framework for that conversation. Here, the missing piece is a reconciled quote, not a lack of advertised numbers.

The website also warns that the price increases if a patient chooses an increase in dosage. That is a commercial condition, not guidance to change treatment. For budgeting, it means the first advertised payment is not a promise of a constant treatment cost. The pages do not establish a price lock, an advance-payment requirement, or how long an individual would remain at a particular listed price.

Sources: [3]

Reading the two medication price schedules

The semaglutide table below preserves the website’s presentation labels and monthly prices. These labels identify advertised options; they are not patient dosing instructions and do not identify a brand, concentration, container, or quantity dispensed. The site generally describes injections under the skin, but it does not fully specify the products attached to these prices. That limits comparisons with another provider’s seemingly similar offer, particularly when the other quote identifies a specific product and supply quantity.

Tirzepatide has a separate four-level schedule: $195 per month for the 2.5 mg listing, $295 for 5 mg, $395 for 7.5 mg, and $495 for 10 mg. The first listing includes the initial consultation; the remaining listings describe monthly checkups and measurement of progress and vital signs. These are published monthly figures, not documented four-week prices. The materials do not define the actual charge date, refill interval, or relationship between a payment period and medication quantity.

A useful comparison therefore requires more than matching medicine names. Ask which presentation the clinician is considering, what exact product would be supplied, and what the corresponding payment includes. The listed amounts should remain visible in that discussion: uncertainty about formulation does not erase the provider’s advertised prices. It does, however, prevent treating those figures as fully specified, all-in offers that can be compared dollar for dollar with every other program.

Slim Now TN’s advertised semaglutide options; labels are not treatment instructions.
Listed presentationAdvertised monthly priceListed clinical service
0.25 mg$85 per monthInitial provider consultation
0.50 mg$125 per monthMonthly checkup; progress and vital-sign measurements
1 mg$200 per monthMonthly checkup; progress and vital-sign measurements
1.50 mg$250 per monthMonthly checkup; progress and vital-sign measurements
2 mg$300 per monthMonthly checkup; progress and vital-sign measurements
Sources: [3]

What the advertised payment appears to include

Slim Now TN connects its medication prices to clinical services rather than presenting them solely as product prices. The initial options describe a provider consultation, instructions for using the medication, and a first administration in the office. Subsequent listings describe monthly checkups, progress measurements, and vital signs. The tables also describe medication for administration at home. These are meaningful inclusions, although they do not establish every operational detail of the consultation or supply process.

The remaining questions concern the edges of that package. The consulted pages do not establish whether laboratory work is required or included, whether extra visits incur charges, or whether supplies, taxes, or other fees apply. They also do not identify insurance acceptance or reimbursement arrangements. It would be inaccurate to add hypothetical fees to the advertised amount, but equally inaccurate to certify that none exist. Our guide to what a GLP-1 program price includes explains how to separate documented inclusions from unanswered items.

There is also no clear statement that these are subscription payments, automatically renewed charges, or invoices collected on another schedule. A monthly label describes the advertised pricing period; it does not by itself authorize conclusions about the payment mechanism. Before enrolling, request an itemized explanation that separates consultation, medication, testing if applicable, and any additional care. Confirm whether the quoted total is collected by the practice alone or whether another organization could bill separately.

Sources: [3]

Local visits, Tennessee telehealth, and the cost of access

The practice lists its Murfreesboro location at 5607 Franklin Rd, Murfreesboro, TN 37128. Published hours are Monday through Thursday, 8 a.m. to 5 p.m.; Friday, 8 a.m. to noon; and every other Saturday, 9 a.m. to 2 p.m. Those details help a prospective patient judge appointment logistics, but the alternating Saturday schedule requires confirmation. The website also advertises telehealth visits in Tennessee. The consulted evidence does not establish availability in other states.

Telehealth could change the practical expense of attending appointments, but the website leaves an important process question open. Its initial medication descriptions say the first dose is administered in the office, without explaining how that works for remote patients. Neither statement should be discarded: telehealth is advertised, and an office-based first administration is described. Ask whether an in-person start is required for the specific arrangement being offered, rather than assuming enrollment can be completed entirely from home.

Scheduling begins by contacting the office. The published telephone number is 615-439-6929, and the email address is info@slimnowtn.com; the site also offers an appointment-request form. These are documented contact paths, not promises of an immediate appointment or a particular response time. No evaluation turnaround, after-hours support arrangement, or Spanish-language care access is established in the consulted materials. Those details may matter when weighing convenience against the monthly charge.

Sources: [3]

Who provides care, and what follow-up is documented

The website identifies Madison Umbeck as FNP-C, MSCP and describes her as a board-certified family nurse practitioner. It attributes her nursing bachelor’s degree to Saint Louis University and master’s degree to Belmont University. J. Seth Weathersby is identified as the owner and a PA-C, a physician assistant credential, with exercise-science and medicine degrees from Trevecca Nazarene University. These are provider-published biographies, not independently verified credentials or evidence that a particular clinician will handle every appointment.

Slim Now TN also says Weathersby serves on Tennessee’s state board for physician assistants and has more than 20 years of urgent-care experience. It lists Shelby Turvey as FNP-C and attributes more than 30 years in health care to her. The biographies help establish whom the business presents as its clinical team, but the consulted pages do not identify the operating legal entity, verify licenses, or specify the assignment and backup arrangements for an individual patient.

For ongoing care, the most concrete promise is the monthly checkup with progress and vital-sign measurements on the later price listings. The documentation does not explain how remote measurements are obtained, who handles questions between appointments, or how additional clinical attention is billed. NIDDK describes follow-up as addressing treatment tolerance and response, not simply renewing payments. Accordingly, a useful cost question is what happens when a patient needs help outside the regularly included visit.

Sources: [3] [2]

Medication identity is an unresolved part of the quote

Slim Now TN advertises semaglutide and tirzepatide, but the consulted material does not identify brand names, manufacturers, exact formulations, or the dispensing pharmacy. A “Pharmacy Partner” link appears in the material, but its destination content was not available in the supplied evidence. Consequently, this review cannot establish whether a particular quoted option is an FDA-approved product or a compounded preparation. The clinic’s medication names alone are insufficient to settle that question.

That distinction has regulatory significance without justifying speculation about this provider. FDA approval attaches to a specific product, not to a clinic or pharmacy. Compounded preparations are not FDA approved and do not undergo FDA premarket review for safety, effectiveness, and quality; that fact alone does not demonstrate clinical inequivalence. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy.

Home administration also does not establish home delivery. The evidence does not specify pickup, shipping charges, packaging, refrigeration, a carrier, or arrival timing. Ask who dispenses the medication and how it reaches the patient before assigning a final value to the advertised package. If an injectable GLP-1 delivery arrives warm or inadequately refrigerated, FDA explicitly advises not using it and contacting the provider or dispensing pharmacy. That is general guidance, not evidence of a shipping problem at Slim Now TN.

Sources: [3] [1]

Renewal, cancellation, and coverage need separate answers

The consulted pages do not publish a minimum commitment, automatic-renewal policy, cancellation deadline, refund policy, prepayment condition, or discount structure. That absence is not proof that enrollment has no ongoing obligations. It means the advertised monthly schedule cannot serve as a complete set of purchase terms. Request the applicable agreement before paying, including when charges occur, how to stop future charges, and what happens if clinical evaluation does not lead to a prescription.

Cancellation and refund rights should be addressed independently. Ending future participation does not necessarily return money already collected, and the available documentation does not establish either outcome here. Our guide to cancellation and refunds explains why the two questions belong in separate lines of a written quote. For Slim Now TN, the practical objective is to obtain the actual rules rather than import assumptions from another clinic or from a familiar subscription service.

Insurance is similarly unresolved: the evidence does not establish accepted plans, medication coverage, or reimbursement procedures. NIDDK notes that some insurance plans cover weight-management medicines and others do not; coverage requires confirmation with the plan. Consultation coverage and medication coverage should not be treated as interchangeable. Ask the office what it can bill, ask the insurer what it covers, and keep those answers separate from the practice’s advertised monthly figures.

Sources: [3] [2]

Keep optional services and website privacy in perspective

Slim Now TN also advertises NAD+, including a 50 mg listing at $50 per month. That is a separate commercial offering, not a documented requirement of its GLP-1 program or a treatment recommendation here. The NAD+ section lists pregnancy or breastfeeding, active cancer, severe liver or kidney failure, and known NAD+ allergies among situations in which it says not to take that product. Those statements must not be repurposed as the clinic’s GLP-1 eligibility rules, which are not fully documented.

The website privacy policy describes collecting comment-form data, IP addresses, and browser identifiers for spam detection, with comments and metadata retained indefinitely. It also describes requests to erase personal data, subject to administrative, legal, or security retention exceptions. Those website provisions do not establish medical-record retention rules or a clinical patient portal. The supplied material does not include the HIPAA link’s contents or enough detail to assess the handling of telehealth clinical information.

Before making a payment, consolidate the unanswered items into one request: reconcile the first-month price, identify the exact medication and pharmacy, explain remote versus office requirements, itemize inclusions, and supply billing and exit terms. Our prepayment question checklist can help organize that request. The point is not to demand certainty about future treatment decisions; it is to understand which financial and service commitments apply to the care being offered now.

Sources: [3] [4]

Questions & answers

Is Slim Now TN’s first month $85 or $195?

Both amounts appear in different contexts. The general program introduction advertises $195 for the first month, while semaglutide’s 0.25 mg listing advertises $85 per month with an initial consultation included. Tirzepatide’s initial 2.5 mg listing is $195 per month. The sources do not reconcile the general offer with semaglutide’s lower listing. Ask for the exact medication-specific amount due before enrollment rather than assuming either figure controls.

Sources: [3]
Does the monthly price include medication and appointments?

The price listings describe medication for home administration and attach clinical services to the options: an initial consultation and use instructions at the beginning, then monthly checkups with progress and vital-sign measurements on later listings. That supports a bundled-service reading, but not a guarantee that every possible expense is included. Laboratory costs, additional visits, supplies, taxes, and other potential charges are not sufficiently specified in the consulted materials.

Sources: [3]
Can Tennessee telehealth patients avoid an office visit?

The website advertises telehealth in Tennessee, but its initial options also describe a first administration in the office. The evidence does not explain whether remote patients follow a different process or must attend in person to begin. Confirm that requirement directly, along with how subsequent progress and vital-sign measurements are handled. The materials do not establish availability outside Tennessee or guarantee a fully remote enrollment pathway.

Sources: [3]
Which pharmacy supplies Slim Now TN’s medication?

The dispensing pharmacy is not identified in the consulted evidence. Nor are the exact brands, manufacturers, or formulations established, so this review cannot classify the supplied products as approved or compounded. Ask the office for the pharmacy’s name and the specific product tied to the quote. The description of administration at home does not establish whether medication is shipped, collected at the practice, or obtained through another arrangement.

Sources: [3]
How do I contact Slim Now TN about a written quote?

The published office number is 615-439-6929, and the email address is info@slimnowtn.com. The website also provides an appointment-request form. Ask the office to confirm the applicable price, included services, payment timing, and medication details in writing. Published hours include weekdays and alternating Saturdays, but the materials do not promise a response deadline, same-day consultation, or clinical support outside office hours.

Sources: [3]
Can I cancel after one month and receive a refund?

The consulted pages do not establish a minimum commitment, cancellation procedure, notice deadline, or refund entitlement. Monthly pricing alone does not answer whether future charges occur automatically or whether money already paid is refundable. Obtain those terms before paying, including what happens if medication has already been ordered or supplied. This is an unresolved documentation issue, not evidence that the practice necessarily requires a long commitment or refuses refunds.

Sources: [3]

Our assessment

Slim Now TN offers a useful starting point for Tennessee patients comparing advertised GLP-1 costs: medication-specific monthly schedules, stated initial and follow-up services, identifiable clinicians, and a physical office with direct contact options. Its documentation is less complete where an advertisement becomes a financial commitment. The first-month discrepancy, unidentified pharmacy and formulations, unclear remote-start process, and missing billing and cancellation terms prevent a confident all-in cost conclusion. A sensible next step is a reconciled written quote and the applicable service agreement—not an assumption that the lowest figure applies or that undocumented charges necessarily exist. The published prices are informative, but the final purchasing decision needs clearer product and payment details.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

  1. FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
  2. NIDDK: prescription medications for overweight and obesity ↗
  3. Slim Now TN — official website ↗
  4. Slim Now TN — privacy policy ↗

Continue reading